Frontotemporal dementia with parkinsonism-17
Last updated 13 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Frontotemporal dementia with parkinsonism-17 (FTDP-17) is a brain disorder. It is part of a group of conditions, called frontotemporal dementia or frontotemporal degeneration, that are characterised by a loss of nerve cells (neurons) in areas of the brain called the frontal and temporal lobes. Over time, a loss of these cells can affect personality, behaviour, language, and movement.
Video picks for Genetic conditionsVideo library
Description
Frontotemporal dementia with parkinsonism-17 (FTDP-17) is a brain disorder. It is part of a group of conditions, called frontotemporal dementia or frontotemporal degeneration, that are characterised by a loss of nerve cells (neurons) in areas of the brain called the frontal and temporal lobes. Over time, a loss of these cells can affect personality, behaviour, language, and movement.
The signs and symptoms of FTDP-17 usually become noticeable in a person's forties or fifties. Most affected people survive 5 to 10 years after the appearance of symptoms, although a few have survived for two decades or more.
Changes in personality and behaviour are often early signs of FTDP-17. These changes include a loss of inhibition, inappropriate emotional responses, restlessness, neglect of personal hygiene, and a general loss of interest in activities and events. The disease also leads to deterioration of cognitive functions (dementia), including problems with judgement, planning, and concentration. Some people with FTDP-17 develop psychiatric symptoms, including obsessive-compulsive behaviors, strongly held false beliefs (delusions), and false perceptions (hallucinations). It may become difficult for affected individuals to interact with others in a socially appropriate manner. They increasingly require help with personal care and other activities of daily living.
Many people with FTDP-17 develop problems with speech and language. They may have trouble finding words, confuse one word with another (semantic paraphasias), and repeat words spoken by others (echolalia). Difficulties with speech and language worsen over time, and most affected individuals eventually lose the ability to communicate.
FTDP-17 is also characterised by problems with movement that worsen over time. Many affected individuals develop features of parkinsonism, including tremors, rigidity, and unusually slow movement (bradykinesia). As the disease progresses, most affected individuals become unable to walk. Some people with FTDP-17 also have restricted up-and-down eye movement (vertical gaze palsy) and rapid abnormal movements of both eyes (saccades).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
DDPAC
Disinhibition-dementia-parkinsonism-amytrophy complex
Familial Pick's disease
FTDP-17
Wilhelmsen-Lynch disease
Patient picks for Genetic conditions

Brain and nerves
Memory loss and dementia
Memory loss has a number of causes, one of which is dementia. Dementia is a progressive condition which causes deteriorating mental function which interferes with activities of daily living.
by Dr Doug McKechnie, MRCGP

Brain and nerves
What causes dementia?
Dementia is a condition that gets worse over time and causes problems with how our brain functions, particularly memory loss and problems with thinking, learning, reasoning, problem solving, and emotions. This increasingly interferes with activities of daily living - until even basic things such as dressing and eating are affected.
by Dr Colin Tidy, MRCGP

Brain and nerves
What are the different types of dementia?
For many people, dementia means Alzheimer's. But Alzheimer's isn't the only type of dementia; there are actually several different forms. What are the differences and how do doctors diagnose each type?
by Glynis Kozma

Brain and nerves
What is the link between Parkinson's disease and dementia?
Parkinson's and dementia are separate conditions, with many people developing one without the other. This said, people with Parkinson's have a higher risk of dementia, particularly during old age. The two main types of dementia that people with Parkinson's can develop are 'Parkinson's dementia' and 'dementia with Lewy bodies'.
by Amberley Davis

Brain and nerves
Causes of memory loss and dementia
Everybody forgets things from time to time. In general, the things that you tend to forget most easily are the things that you feel do not matter as much.
by Dr Doug McKechnie, MRCGP

Brain and nerves
Is it dementia or just forgetfulness?
I've never met a patient over 50 (and sometimes earlier) who doesn't worry about dementia. Forgetfulness is common, especially as you get older. But should you be laughing it off or seeing your doctor?
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Memory loss and dementia
Lewy body dementia This is a type of dementia caused by lumps of protein in... Frontotemporal dementia This is a type of dementia that causes the frontal and temporal lobes of the brain to shrink and stop working. Other types of dementia There are many other types of dementia, such as: Dementia due to Parkinson's disease Parkinson's disease. The.

Patient information leaflet
Causes of memory loss and dementia
People with Down's syndrome are more likely to develop Alzheimer's disease. Parkinson's disease Parkinson's disease. As many as half of people with Parkinson's disease may develop dementia. If Lewy bodies develop in a part of the brain called the brain stem, as well as symptoms of dementia, someone may also develop symptoms similar to Parkinson's.

Patient information leaflet
Parkinson's disease
Parkinson's disease is a progressive... The cells in the brain affected in PD are not in the 'thinking' parts of the brain and dementia is not a typical early feature of PD Memory loss and dementia. About half of people with Parkinson's disease develop dementia at some stage. If dementia occurs, it tends to develop in older people with PD (aged.

Patient information leaflet
Temporal lobe lesions
A serious head injury Head injuries or a surgical operation to remove a brain tumour may may also cause damage or injury to the temporal lobe. Progressive worsening of language can be part of a type of dementia Memory loss and dementia called frontotemporal dementia. Frontotemporal dementia The temporal lobe can be affected by an infection of the.

Patient information leaflet
Apathy
Apathy is also associated with various other conditions, including various types of dementia Memory loss and dementia , Parkinson's disease Parkinson's disease and multiple sclerosis Multiple sclerosis , and following a stroke Stroke. Diagnosing apathy The diagnosis of apathy is made by a health professional based on: Your medical and medication.

Patient information leaflet
Medication and treatment for dementia
However, doctors should never work outside of their skills and many GPs may stil... The medicine rivastigmine is also licensed to be used in people with mild-to-moderately severe dementia who also have Parkinson's disease Parkinson's disease. Also, an acetylcholinesterase inhibitor medicine may sometimes be suggested for people with dementia with.
Further reading and references
- Frontotemporal dementia with parkinsonism-17; MedlinePlus, National Library of Medicine.
- Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol. 2008 Apr;65(4):460-4. doi: 10.1001/archneur.65.4.460.
- Cohn-Hokke PE, Elting MW, Pijnenburg YA, van Swieten JC. Genetics of dementia: update and guidelines for the clinician. Am J Med Genet B Neuropsychiatr Genet. 2012 Sep;159B(6):628-43. doi: 10.1002/ajmg.b.32080. Epub 2012 Jul 19.
- Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998 Jun 18;393(6686):702-5. doi: 10.1038/31508.
- Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Hoglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP, Wagner S, Wszolek ZK; Reisensburg Working Group for Tauopathies With Parkinsonism. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009 Mar;16(3):297-309. doi: 10.1111/j.1468-1331.2008.02513.x.
- Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003 Sep;126(Pt 9):2016-22. doi: 10.1093/brain/awg204. Epub 2003 Jul 22.
- Spillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics. 2000 Mar;2(4):193-205. doi: 10.1007/pl00022972.
- van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 2007 Jan;17(1):63-73. doi: 10.1111/j.1750-3639.2007.00052.x.
- van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, Kamphorst W, Ravid R, Spillantini MG, Niermeijer, Heutink P. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol. 1999 Oct;46(4):617-26. doi: 10.1002/1531-8249(199910)46:43.0.co;2-i.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

